Prevalence and incidence of neuropsychiatric disorders in post hospitalized COVID-19 patients in South America: a systematic review and meta-analysis

Frontiers in Psychiatry, Год журнала: 2023, Номер 14

Опубликована: Ноя. 1, 2023

There are multiple reports of neuropsychiatric disorders (NDs) such as stress, depression, post-traumatic stress disorder (PTSD), or anxiety, in patients who have survived the acute phase COVID-19, being even more frequent people were hospitalized with moderate severe disease. South America (SA) was one most affected continents during this time due to its health, social, political and economic context. We aimed determine prevalence incidence NDs following hospitalization for COVID-19 SA.We searched PubMed, Embase, Scopus, Web Science, LILACS, SciELO, Google Scholar databases up October 2022. performed proportion meta-analysis a random-effect model Freeman-Tukey Double Arcsine transformation using STATA 16.1 program. Finally, we evaluated heterogeneity by subgroup analysis certainty evidence GRADE approach.We included eight studies from four countries. only pooled six measures. The estimated all 31.48% (two-studies, 95%CI: 25.82-37.43). Depression, insomnia, PTSD, memory alterations had 16.23% (three-studies, 7.18-27.93, I2: 94.22), 18.72% 11.65-26.97, 87.56), 43.07% 32.77-53.37, 92.61), 31.78% 14.33-52.40, 97.96), 38.24% 35.5-40.97), respectively. deemed high certainty.We suggest that should be prioritized research care public policies can support their identification prompt management improve quality life patients. More needed adequately study America, associated factors, evaluate causes heterogeneity.https://doi.org/10.6084/m9.figshare.21901041.v1.

Язык: Английский

---

Association between previous SARs-CoV-2 infection and new prescription of antidepressant drugs: a case-control study in Friuli Venezia Giulia Region, Italy

Research Square (Research Square), Год журнала: 2024, Номер unknown

Опубликована: Янв. 16, 2024

Abstract Purpose: A rise in affective and anxiety disorders antidepressant (AD) treatment during the COVID-19 pandemic has been extensively described, but few studies were provided at individual level, further considering severity vaccination status. Methods: Case-control study evaluating association between new use of ADs a previous infection, Friuli Venezia Giulia Region, Italy, from March 1, 2020, to July 19, 2022. Multiple conditional logistic regressions assess AD infection index date, stratified by gender, age anti-COVID-19 Odds Ratios (OR) 95% confidence intervals reported. Results : was associated with after infection. The disease positively growing risk being dispensed an AD, highest unvaccinated subjects previously hospitalised ICU (OR=28.77). using higher aged 65 years older, both females males. dispensation vaccinated not significant, exception over. Conclusions: Anti-COVID-19 vaccination, especially among elderly, might prevent post-COVID depressive symptoms. Clinicians should be aware that patients requiring hospitalisation are more likely experience these symptoms, given their ADs. Future may benefit analysing incidence mental psychotropic patients, socioeconomic factors

Язык: Английский

---

Novel Advancements in COVID-19 and Neuroscience

Journal of Personalized Medicine, Год журнала: 2024, Номер 14(2), С. 143 - 143

Опубликована: Янв. 28, 2024

From an initial cluster of cases reported in Wuhan, the SARS-Cov-2 infection has since spread globally, causing a pandemic that began on 11 March 2020 [...]

Язык: Английский

---

Longitudinal trajectories of psychosocial functioning in patients with pre-existing mental disorders after one year of COVID-19 pandemic

Journal of Psychiatric Research, Год журнала: 2024, Номер 172, С. 200 - 209

Опубликована: Фев. 15, 2024

Aims of the present study were to prospectively assess psychosocial functioning trajectories during COVID pandemic and possible impact sociodemographic variables, as well COVID-19 pandemic-related factors, on these trajectories, in a sample patients with pre-existing severe mental disorders. Moreover, we aimed at identifying predictors impairment over period 9 months pandemic. Patients recruited 3rd wave (T0, March-April 2021) while strict containment measures applied Italy, reassessed after 3 (T1, June-July 2021), 6 from T1 (T2- November-December 4th A 300 subject (out 527 subjects baseline) completed T2 evaluation. assessed by: Work Social Adjustment Scale (WSAS) for functioning, Generalized Anxiety Disorder 7-Item (GAD-7) anxiety symptoms, Patient Health Questionnaire-9 (PHQ-9) depressive symptoms Impact Events Scale-Revised, post-traumatic symptoms. Cluster analyses identified 4 functioning: High, Stable Functioning group (N = 77), Improvement 62), Progressive Impairment 83) Persistent Severe 78) respectively. We found that higher WSAS score T0 (B 0.43, p < .001), PHQ scores baseline >10 2.89, .05), not living alone was be protective factor -2.5, .05). Results provides insights into vulnerability individuals psychiatric disorders times crisis. Study findings can contribute better understanding specific needs this population inform interventions support strategies.

Язык: Английский

---

DYNAMICS OF PSYCHOPATHOLOGICAL SYMPTOMS IN THE POST-COVID-19 PERIOD

World of Medicine and Biology, Год журнала: 2024, Номер 20(87), С. 31 - 31

Опубликована: Янв. 1, 2024

Язык: Английский

---